Avalo Therapeutics GAAP EPS of -$2.19
Source: SeekingAlpha
2025-11-06 07:47:59 ET
More on Avalo Therapeutics
- Avalo Therapeutics: Speculative Buy Ahead Of AVTX-009's LOTUS Results
- Avalo gains as Cantor initiates with bullish view on lead asset
- Seeking Alpha’s Quant Rating on Avalo Therapeutics
- Historical earnings data for Avalo Therapeutics
- Financial information for Avalo Therapeutics
Read the full article on Seeking Alpha
For further details see:
Avalo Therapeutics GAAP EPS of -$2.19
Avalo Therapeutics Inc.
NASDAQ: AVTX
AVTX Trading
-2.34% G/L:
$17.50 Last:
174,154 Volume:
$17.19 Open:
AVTX Latest News
November 17, 2025 04:30:00 pm
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
November 06, 2025 07:00:00 am
Avalo Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates
AVTX Stock Data
$270,471,380
10,627,775
1.79%
15
N/A
Biotechnology & Life Sciences
Healthcare
US
Wayne
